We have used the same study design as in our publication on SRCCs [6], thereby enabling researchers and clinicians to also directly compare MAs to SRCCs, which can have utility in future studies to improve understanding of rare cancers defined by mucin-production disorders. Here, MUC5AC is linked to cancer.